Vilsan Quality Standards
As a symbol of excellence in veterinary pharmaceutical production, Vilsan fully complies with the 11th Edition of the European Pharmacopoeia (Ph. Eur.). Developed by the Council of Europe, the European Pharmacopoeia provides comprehensive quality standards for active ingredients and excipients used in the production of pharmaceutical products. The 11th Edition of the Ph. Eur. became legally binding in 39 European countries as of January 1, 2023, and is accepted and implemented by many countries worldwide.
The monographs of the European Pharmacopoeia define the chemical, physical, and microbiological properties of pharmaceutical products and active ingredients, and these standards are essential to ensure the safety of consumers and professionals. At Vilsan, compliance with these standards is not only a legal requirement but also a commitment to reliability and quality.
Vilsan's production processes are managed in accordance with all quality standards established by the 11th Edition of the Ph. Eur. At our production facility, modern production lines with GMP (Good Manufacturing Practice) certification ensure meticulous control at every stage, ensuring quality throughout the entire process, from raw materials to the final product.
Active ingredients and excipients are procured in accordance with the standards set by Ph. Eur. 11. Every ingredient used in production undergoes detailed analysis for compliance with the European Pharmacopoeia and is verified through chemical, physical, and microbiological tests. These tests ensure not only product efficacy but also safety.
Vilsan's quality mission is based on the understanding that every product we produce, from raw material selection to modern production technology that adheres to quality standards, will benefit animal health and support the success of veterinarians.
